Drugs, violence, and a "thumbs up" button will color in the week that lies ahead.
Let's start off the trading week in our lab coats, as we dig into volatile biotech upstart Myogen
Don't tune in for a monster quarter on Monday; analysts expect sharp losses. Do tune in to hear about any more progress on the ambrisentan front.
Investors in Take-Two Interactive
Dude, where's my investment vehicle?
The stock has been rocked as Take-Two and many of the other leading video-game makers are struggling with gamers who have been holding up on buying new titles until all three next-generation consoles hit the market. Tuesday's report will reveal as such. In short, the company may have had a strong holiday quarter showing a year ago, but red ink will spill this time around.
It's mid-week TiVo
We just had a Dueling Fools segment on IMAX
The stock is also an active Motley Fool Rule Breakers selection. As the conventional multiplex cinema fades in popularity, some would argue that the theater business is a bad to place to be, but I believe that a sector worth disrupting is ripe with opportunities.
The end of the trading week brings "the mother of all search engines" to the earnings podium. Mamma.com
Until next week, I remain,
Longtime Fool contributor Rick Munarriz recommends windshield wiper fluid when trying to look forward. He does not own shares in any of the companies in this story. The Fool has a disclosure policy. Rick is also part of the Rule Breakers newsletter research team, seeking out tomorrow's ultimate growth stocks a day early.